These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6184880)

  • 1. On the inhibition of interferon action by inhibitors of fatty acid cyclooxygenase.
    Sarkar FH; Gupta SL
    Virology; 1982 Dec; 123(2):448-51. PubMed ID: 6184880
    [No Abstract]   [Full Text] [Related]  

  • 2. Pleiotropic activities of human interferons are mediated by multiple response pathways.
    Forti RL; Mitchell WM; Hubbard WC; Workman RJ; Forbes JT
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):170-4. PubMed ID: 6320163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to interferon of LM cells growing continuously in the absence of serum and exogenous lipids.
    Milhaud PG; Faure T; Chaintreuil J; Cathala JM; Lebleu B
    J Gen Virol; 1983 Feb; 64 (Pt 2)():485-9. PubMed ID: 6187895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of procaine and oxyphenylbutazone on interferon-mediated inhibition of murine leukemia virus production.
    Herz RE; Sen GC
    Antiviral Res; 1983 Sep; 3(3):189-94. PubMed ID: 6197028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and aspirin do not inhibit the antiviral or anti-proliferative actions of interferon.
    Tovey MG; Gresser I; Rochette-Egly C; Begon-Lours-Guymarho J; Bandu MT; Maury C
    J Gen Virol; 1982 Dec; 63(2):505-8. PubMed ID: 6185629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indomethacin on the antiviral and priming effect of interferon.
    Rosztóczy I
    Acta Virol; 1978 May; 22(3):254. PubMed ID: 27979
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of butyrate on induction and action of interferon.
    Adolf GR; Swetly P
    Biochem Biophys Res Commun; 1981 Dec; 103(3):806-12. PubMed ID: 6174120
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of "Aquasol A", vitamin A, and "Tween 80" on vesicular stomatitis virus plaque formation and on interferon action.
    Blalock JE; Gifford GE
    Arch Gesamte Virusforsch; 1974; 45(1-2):161-4. PubMed ID: 4369949
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishment of the interferon-mediated antiviral state: role of fatty acid cyclooxygenase.
    Pottathil R; Chandrabose KA; Cuatrecasas P; Lang DJ
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5437-40. PubMed ID: 6159647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced responsiveness of L-929 cells treated with interferon to arginine starvation.
    Lee SH; Rozee KR
    Exp Cell Res; 1975 Jun; 93(1):142-51. PubMed ID: 166850
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of inhibitors of interferon action by cell lines sensitive and insensitive to the antiviral action of interferon].
    Khesin IaE; Parfenov VV; Amchenkova AM; Narovlianskiĭ AN; Tkach TA
    Vopr Virusol; 1985; 30(5):584-6. PubMed ID: 2416134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid increase in guanosine 3',5'-cyclic-monophosphate interferon treated mouse leukemia L1210 cells: relationship to the development of the antiviral state and inhibition of cell multiplication.
    Tovey MG; Rochette-Egly C
    Virology; 1981 Dec; 115(2):272-81. PubMed ID: 6171931
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholera toxin and its B subunit inhibit interferon effects on virus production and erythroid differentiation of Friend leukemia cells.
    Belardelli F; Ausiello C; Tomasi M; Rossi GB
    Virology; 1980 Nov; 107(1):109-20. PubMed ID: 6160675
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK; Friedman RM
    Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of the serum inhibitory factor on interferon induction in chronic active hepatitis].
    Tang SB
    Zhonghua Nei Ke Za Zhi; 1983 Mar; 22(3):159-61. PubMed ID: 6191928
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative aspects of interferon-induced plaque reduction: effects of cell age and dose of challenge virus.
    Jordan GW; Merigan TC
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):1037-41. PubMed ID: 4362002
    [No Abstract]   [Full Text] [Related]  

  • 17. Equine interferon: characterization of a viral inhibitor induced in equine kidney cell cultures with statolon.
    Ley KD; Burger D; Henson JB
    J Infect Dis; 1970 Mar; 121(3):335-8. PubMed ID: 4313279
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
    Thacore HR; Youngner JS
    Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity.
    Maheshwari RK; Friedman RM
    Virology; 1980 Mar; 101(2):399-407. PubMed ID: 6244697
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon.
    Degré M
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):253-5. PubMed ID: 202975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.